{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Device-Based Therapies for Hypertension Management"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was computer-generated"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adults with resistant hypertension, recruited from multiple clinical centers."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received catheter-based renal denervation (RDN), while the control group received standard antihypertensive medication."
      },
      "Objective": {
        "score": 1,
        "evidence": "To assess the effectiveness of RDN in reducing blood pressure compared to standard treatment."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in systolic blood pressure (SBP) over six months."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment ensured by sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised: 100 to the RDN group and 100 to the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the RDN group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The RDN group showed a significant reduction in SBP (mean difference = 5.2 mm Hg, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, with 3% in the RDN group and 1% in the control group experiencing side effects."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678"
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Institutes of Health."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}